Based on our research, we postulate that specifically upregulating LBH during NPC therapy might ameliorate tumor metastasis and angiogenesis, achieving better therapeutic efficacy for NPC patients via exosome-mediated VEGFA inhibition, and this is likely our next research topic. The gene discussed is VEGFA; the disease is nasopharyngeal carcinoma.